-
1
-
-
84996602597
-
Sex difference in chronic obstructive lung disease. Does it matter?
-
Kokturk N, Kilic H, Baha A, Lee SD, Jones PW. Sex difference in chronic obstructive lung disease. Does it matter? A concise review. COPD. 2016; 13(6):799–806.
-
(2016)
A concise review. COPD.
, vol.13
, Issue.6
, pp. 799-806
-
-
Kokturk, N.1
Kilic, H.2
Baha, A.3
Lee, S.D.4
Jones, P.W.5
-
2
-
-
84921407489
-
Mortality trends in women and men with COPD in Ontario, Canada, 1996–2012
-
Gershon A, Hwee J, Victor JC, Wilton A, Wu R, Day A, et al. Mortality trends in women and men with COPD in Ontario, Canada, 1996–2012. Thorax. 2015; 70(2):121–126.
-
(2015)
Thorax.
, vol.70
, Issue.2
, pp. 121-126
-
-
Gershon, A.1
Hwee, J.2
Victor, J.C.3
Wilton, A.4
Wu, R.5
Day, A.6
-
3
-
-
84901408169
-
Cigarette smoking among women: how can we help?
-
Allen SS. Cigarette smoking among women:how can we help? Minn Med. 2014; 97(3):41–43.
-
(2014)
Minn Med.
, vol.97
, Issue.3
, pp. 41-43
-
-
Allen, S.S.1
-
4
-
-
77953689989
-
Gender differences in COPD: are women more susceptible to smoking effects than men?
-
Sorheim IC, Johannessen A, Gulsvik A, Bakke PS, Silverman EK, DeMeo DL. Gender differences in COPD:are women more susceptible to smoking effects than men? Thorax. 2010; 65(6):480–485.
-
(2010)
Thorax.
, vol.65
, Issue.6
, pp. 480-485
-
-
Sorheim, I.C.1
Johannessen, A.2
Gulsvik, A.3
Bakke, P.S.4
Silverman, E.K.5
DeMeo, D.L.6
-
5
-
-
0025809099
-
Increased susceptibility to lung dysfunction in female smokers
-
Chen Y, Horne SL, Dosman JA. Increased susceptibility to lung dysfunction in female smokers. Am Rev Respir Dis. 1991; 143(6):1224–1230.
-
(1991)
Am Rev Respir Dis.
, vol.143
, Issue.6
, pp. 1224-1230
-
-
Chen, Y.1
Horne, S.L.2
Dosman, J.A.3
-
6
-
-
33645775057
-
Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis
-
Gan WQ, Man SF, Postma DS, Camp P, Sin DD. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease:a systematic review and meta-analysis. Respir Res. 2006; 7:52.
-
(2006)
Respir Res.
, vol.7
, pp. 52
-
-
Gan, W.Q.1
Man, S.F.2
Postma, D.S.3
Camp, P.4
Sin, D.D.5
-
7
-
-
84862954728
-
Gender differences in susceptibility to smoking among patients with lung cancer
-
Ryu JS, Jeon SH, Kim JS, Lee JH, Kim SH, Hong JT, et al. Gender differences in susceptibility to smoking among patients with lung cancer. Korean J Intern Med. 2011; 26(4):427–431.
-
(2011)
Korean J Intern Med.
, vol.26
, Issue.4
, pp. 427-431
-
-
Ryu, J.S.1
Jeon, S.H.2
Kim, J.S.3
Lee, J.H.4
Kim, S.H.5
Hong, J.T.6
-
8
-
-
84857888066
-
Sex differences and sex steroids in lung health and disease
-
Townsend EA, Miller VM, Prakash YS. Sex differences and sex steroids in lung health and disease. Endocr Rev. 2012; 33(1):1–47.
-
(2012)
Endocr Rev.
, vol.33
, Issue.1
, pp. 1-47
-
-
Townsend, E.A.1
Miller, V.M.2
Prakash, Y.S.3
-
9
-
-
85027463833
-
Chronic obstructive pulmonary disease: the impact of gender
-
Raghavan D, Varkey A, Bartter T. Chronic obstructive pulmonary disease:the impact of gender. Curr Opin Pulm Med. 2016; 10(2):98–103.
-
(2016)
Curr Opin Pulm Med.
, vol.10
, Issue.2
, pp. 98-103
-
-
Raghavan, D.1
Varkey, A.2
Bartter, T.3
-
10
-
-
84894252586
-
Impact of gender on COPD expression in a real-life cohort
-
Roche N, Deslee G, Caillaud D, Brinchault G, Court-Fortune I, Nesme-Meyer P, et al. Impact of gender on COPD expression in a real-life cohort. Respir Res. 2014; 15:20.
-
(2014)
Respir Res.
, vol.15
, pp. 20
-
-
Roche, N.1
Deslee, G.2
Caillaud, D.3
Brinchault, G.4
Court-Fortune, I.5
Nesme-Meyer, P.6
-
11
-
-
85014533363
-
Improving the Management of COPD in Women
-
Jenkins CR, Chapman KR, Donohue JF, Roche N, Tsiligianni I, Han MK. Improving the Management of COPD in Women. Chest. 2017; 151(3):686–696.
-
(2017)
Chest.
, vol.151
, Issue.3
, pp. 686-696
-
-
Jenkins, C.R.1
Chapman, K.R.2
Donohue, J.F.3
Roche, N.4
Tsiligianni, I.5
Han, M.K.6
-
12
-
-
84880229392
-
Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study
-
Bateman ED, Ferguson GT, Barnes N, Gallagher N, Green Y, Henley M, et al. Dual bronchodilation with QVA149 versus single bronchodilator therapy:the SHINE study. Eur Respir J. 2013; 42(6):1484–1494.
-
(2013)
Eur Respir J.
, vol.42
, Issue.6
, pp. 1484-1494
-
-
Bateman, E.D.1
Ferguson, G.T.2
Barnes, N.3
Gallagher, N.4
Green, Y.5
Henley, M.6
-
13
-
-
84884819644
-
Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN study
-
Dahl R, Chapman KR, Rudolf M, Mehta R, Kho P, Alagappan VK, et al. Safety and efficacy of dual bronchodilation with QVA149 in COPD patients:the ENLIGHTEN study. Respir Med. 2013; 107(10):1558–1567.
-
(2013)
Respir Med.
, vol.107
, Issue.10
, pp. 1558-1567
-
-
Dahl, R.1
Chapman, K.R.2
Rudolf, M.3
Mehta, R.4
Kho, P.5
Alagappan, V.K.6
-
14
-
-
84877131237
-
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study
-
Wedzicha JA, Decramer M, Ficker JH, Niewoehner DE, Sandstrom T, Taylor AF, et al. Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK):a randomised, double-blind, parallel-group study. Lancet Respir Med. 2013; 1(3):199–209.
-
(2013)
Lancet Respir Med.
, vol.1
, Issue.3
, pp. 199-209
-
-
Wedzicha, J.A.1
Decramer, M.2
Ficker, J.H.3
Niewoehner, D.E.4
Sandstrom, T.5
Taylor, A.F.6
-
15
-
-
84933526262
-
LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD
-
Zhong N, Wang C, Zhou X, Zhang N, Humphries M, Wang L, et al. LANTERN:a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD. Int J Chron Obstruct Pulm Dis. 2015; 10:1015–1026.
-
(2015)
Int J Chron Obstruct Pulm Dis.
, vol.10
, pp. 1015-1026
-
-
Zhong, N.1
Wang, C.2
Zhou, X.3
Zhang, N.4
Humphries, M.5
Wang, L.6
-
16
-
-
84877676197
-
Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study
-
Vogelmeier CF, Bateman ED, Pallante J, Alagappan VK, D'Andrea P, Chen H, et al. Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE):a randomised, double-blind, parallel group study. Lancet Respir Med. 2013; 1(1):51–60.
-
(2013)
Lancet Respir Med.
, vol.1
, Issue.1
, pp. 51-60
-
-
Vogelmeier, C.F.1
Bateman, E.D.2
Pallante, J.3
Alagappan, V.K.4
D'Andrea, P.5
Chen, H.6
-
17
-
-
84994164544
-
Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: Pooled analysis of SHINE and ARISE
-
Asai K, Hirata K, Hashimoto S, Fukuchi Y, Kitawaki T, Ikeda K, et al. Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD:Pooled analysis of SHINE and ARISE. Respir Investig. 2016; 54(6):428–435.
-
(2016)
Respir Investig.
, vol.54
, Issue.6
, pp. 428-435
-
-
Asai, K.1
Hirata, K.2
Hashimoto, S.3
Fukuchi, Y.4
Kitawaki, T.5
Ikeda, K.6
-
18
-
-
84896317485
-
Clinical characteristics and quality of life in women with COPD: an observational study
-
Raherison C, Tillie-Leblond I, Prudhomme A, Taille C, Biron E, Nocent-Ejnaini C, et al. Clinical characteristics and quality of life in women with COPD:an observational study. BMC Womens Health. 2014; 14(1):31.
-
(2014)
BMC Womens Health.
, vol.14
, Issue.1
, pp. 31
-
-
Raherison, C.1
Tillie-Leblond, I.2
Prudhomme, A.3
Taille, C.4
Biron, E.5
Nocent-Ejnaini, C.6
-
19
-
-
84994330139
-
Sex/gender differences in smoking cessation: A review
-
Smith PH, Bessette AJ, Weinberger AH, Sheffer CE, McKee SA. Sex/gender differences in smoking cessation:A review. Prev Med. 2016; 92:135–140.
-
(2016)
Prev Med.
, vol.92
, pp. 135-140
-
-
Smith, P.H.1
Bessette, A.J.2
Weinberger, A.H.3
Sheffer, C.E.4
McKee, S.A.5
-
20
-
-
13444250953
-
The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial
-
Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE, et al. The effects of a smoking cessation intervention on 14.5-year mortality:a randomized clinical trial. Ann Intern Med. 2005; 142(4):233–239.
-
(2005)
Ann Intern Med.
, vol.142
, Issue.4
, pp. 233-239
-
-
Anthonisen, N.R.1
Skeans, M.A.2
Wise, R.A.3
Manfreda, J.4
Kanner, R.E.5
Connett, J.E.6
-
21
-
-
78349287385
-
Sex-related differences in COPD in five Latin American cities: the PLATINO study
-
Lopez Varela MV, Montes de Oca M, Halbert RJ, Muino A, Perez-Padilla R, Talamo C, et al. Sex-related differences in COPD in five Latin American cities:the PLATINO study. Eur Respir J. 2010; 36(5):1034–1041.
-
(2010)
Eur Respir J.
, vol.36
, Issue.5
, pp. 1034-1041
-
-
Lopez Varela, M.V.1
Montes de Oca, M.2
Halbert, R.J.3
Muino, A.4
Perez-Padilla, R.5
Talamo, C.6
-
22
-
-
79551509360
-
Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience
-
Celli B, Vestbo J, Jenkins CR, Jones PW, Ferguson GT, Calverley PM, et al. Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med. 2011; 183(3):317–322.
-
(2011)
Am J Respir Crit Care Med.
, vol.183
, Issue.3
, pp. 317-322
-
-
Celli, B.1
Vestbo, J.2
Jenkins, C.R.3
Jones, P.W.4
Ferguson, G.T.5
Calverley, P.M.6
-
23
-
-
85019768559
-
Call to action: improving primary care for women with COPD
-
Tsiligianni I, Rodrí-guez MR, Lisspers K, LeeTan T, Infantino A. Call to action:improving primary care for women with COPD. NPJ Prim Care Respir Med. 2017; 27(1):11.
-
(2017)
NPJ Prim Care Respir Med.
, vol.27
, Issue.1
, pp. 11
-
-
Tsiligianni, I.1
Rodrí-guez, M.R.2
Lisspers, K.3
LeeTan, T.4
Infantino, A.5
-
24
-
-
0037252102
-
The risk of osteoporosis in Caucasian men and women with obstructive airways disease
-
Sin DD, Man JP, Man SF. The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med. 2003; 114(1):10–14.
-
(2003)
Am J Med.
, vol.114
, Issue.1
, pp. 10-14
-
-
Sin, D.D.1
Man, J.P.2
Man, S.F.3
-
25
-
-
84939514891
-
Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures: a population-based cohort study
-
Chen SJ, Liao WC, Huang KH, Lin CL, Tsai WC, Kung PT, et al. Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures:a population-based cohort study. QJM. 2015; 108(8):633–640.
-
(2015)
QJM.
, vol.108
, Issue.8
, pp. 633-640
-
-
Chen, S.J.1
Liao, W.C.2
Huang, K.H.3
Lin, C.L.4
Tsai, W.C.5
Kung, P.T.6
-
27
-
-
84937164147
-
Women with severe obesity and relatively low bone mineral density have increased fracture risk
-
Cawsey S, Padwal R, Sharma AM, Wang X, Li S, Siminoski K. Women with severe obesity and relatively low bone mineral density have increased fracture risk. Osteoporos Int. 2015; 26(1):103–111.
-
(2015)
Osteoporos Int.
, vol.26
, Issue.1
, pp. 103-111
-
-
Cawsey, S.1
Padwal, R.2
Sharma, A.M.3
Wang, X.4
Li, S.5
Siminoski, K.6
-
28
-
-
1542301591
-
Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase
-
Barnes PJ, Ito K, Adcock IM. Corticosteroid resistance in chronic obstructive pulmonary disease:inactivation of histone deacetylase. Lancet. 2004; 363(9410):731–733.
-
(2004)
Lancet.
, vol.363
, Issue.9410
, pp. 731-733
-
-
Barnes, P.J.1
Ito, K.2
Adcock, I.M.3
-
29
-
-
84855896477
-
The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications
-
Tamimi A, Serdarevic D, Hanania NA. The effects of cigarette smoke on airway inflammation in asthma and COPD:therapeutic implications. Respir Med. 2012; 106(3):319–328.
-
(2012)
Respir Med.
, vol.106
, Issue.3
, pp. 319-328
-
-
Tamimi, A.1
Serdarevic, D.2
Hanania, N.A.3
-
30
-
-
40649084813
-
Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial
-
Choudhury AB, Dawson CM, Kilvington HE, Eldridge S, James WY, Wedzicha JA, et al. Withdrawal of inhaled corticosteroids in people with COPD in primary care:a randomised controlled trial. Respir Res. 2007; 8:93.
-
(2007)
Respir Res.
, vol.8
, pp. 93
-
-
Choudhury, A.B.1
Dawson, C.M.2
Kilvington, H.E.3
Eldridge, S.4
James, W.Y.5
Wedzicha, J.A.6
-
31
-
-
84903812277
-
Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)
-
Rossi A, Guerriero M, Corrado A, Group OAS. Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation:a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO). Respir Res. 2014; 15:77.
-
(2014)
Respir Res.
, vol.15
, pp. 77
-
-
Rossi, A.1
Guerriero, M.2
Corrado, A.3
Group, O.A.S.4
-
32
-
-
84916240063
-
INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD
-
Rossi A, van der Molen T, del Olmo R, Papi A, Wehbe L, Quinn M, et al. INSTEAD:a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD. Eur Respir J. 2014; 44(6):1548–1556.
-
(2014)
Eur Respir J.
, vol.44
, Issue.6
, pp. 1548-1556
-
-
Rossi, A.1
van der Molen, T.2
del Olmo, R.3
Papi, A.4
Wehbe, L.5
Quinn, M.6
-
33
-
-
85014789444
-
Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD EXECUTIVE SUMMARY
-
Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report:GOLD EXECUTIVE SUMMARY. Am J Respir Crit Care Med. 2017; 195(5):557–582.
-
(2017)
Am J Respir Crit Care Med.
, vol.195
, Issue.5
, pp. 557-582
-
-
Vogelmeier, C.F.1
Criner, G.J.2
Martinez, F.J.3
Anzueto, A.4
Barnes, P.J.5
Bourbeau, J.6
|